Patients identified by nuclear stress testing as having severe stress-induced myocardial ischemia (lack of blood flow to the heart) are likely to benefit from heart bypass surgery or angioplasty, while those with mild or ...
Jul 11, 2022
0
11
A study supported in part by the EU-funded PREVENT-2024 project has found that simultaneously measuring dozens of types of fat in the blood can help predict the risk of developing T2D and CVD decades before onset. By using ...
Jul 5, 2022
0
2
Migraines may raise the risks for cardio-cerebrovascular diseases (CCDs), particularly in women, according to a study recently published in the Journal of Clinical Neurology.
Jul 5, 2022
0
2
The historical discriminatory housing policies known as "redlining" are associated with heart disease and related risk factors today in impacted neighborhoods, more than 60 years after they were banned, according to a study ...
Jul 4, 2022
0
73
A deep neural network can be used to classify coronary artery disease from clinical heart disease features, according to new work published in the International Journal of Dynamical Systems and Differential Equations.
Jun 30, 2022
0
2
Science has long established a link between depression and cardiovascular disease, but the precise nature of the connection is less clear. In a new proof-of-concept study, researchers worked to zero in on the mechanism behind ...
Jun 22, 2022
0
2
A new study shows targeting a protein in smooth muscle cells can block and decrease buildup of atherosclerotic plaque in mouse models, according to researchers with UTHealth Houston.
Jun 16, 2022
0
33
Researchers identified a greater increase in functional capacity, the ability to perform activities of daily living, as a result of Nordic walking in patients with coronary heart disease compared to standard high-intensity ...
Jun 15, 2022
0
14
The relative rates of hospital contacts for coagulation disorder and cerebrovascular disease are increased after AZD1222 COVID-19 vaccination, particularly for thrombocytopenia and cerebral venous thrombosis, according to ...
Jun 14, 2022
0
29
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound ...
Jun 14, 2022
0
8
